EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

From Validation to Clinical Interpretation: A Flow Cytometric Th17‐Cell Assay for STAT1 ‐ and STAT3 ‐Related Inborn Errors of Immunity

Marie Juhl Toft iD, Camilla Darum Sørensen, Mette Christiansen iD, Carsten Schade Larsen iD, Mette Holm iD, Dinna Nedergaard, Rita Hansen, Lone Højbjerg Egedal, Nicklas Heine Staunstrup iD, Bjarne Kuno Møller iD, Mikkel Steen Petersen iD, Jens Magnus Bernth Jensen iD

Scandinavian Journal of Immunology · 2026-08 · 104 (2)

DOI: 10.1111/sji.70140 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scandinavian Journal of Immunology, online erschienen am 13.08.2026. Verfasst von Marie Juhl Toft und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Th17 Cells, Flow Cytometry, STAT1 Transcription Factor. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Innovation Fund Denmark, Innovationsfonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Th17‐cells are crucial for defence against fungal and bacterial infections and deficiency characterises certain inborn errors of immunity (IEI), including STAT3 ‐related Hyper IgE syndrome (HIES) and STAT1 ‐related Chronic Mucocutaneous Candidiasis (CMC). Standardised methods for clinical Th17‐cell quantification are limited. We developed a flow cytometric assay for quantifying Th17‐cells in peripheral blood based on PMA/ionomycin stimulation and intracellular IL‐17 labeling and evaluated its precision, robustness and longitudinal stability. A reference interval was established in 51 healthy adults and the impact of age and sex was assessed. The assay was applied to 31 patients carrying STAT1 or STAT3 variants or presenting phenotypes for which Th17‐cell quantification is informative. Diagnostic performance was analysed using receiver operating characteristic (ROC) curves and Matthew's Correlation Coefficients (MCC). The assay showed high intra‐ and inter‐assay precision (CV 5.1% and 10%) and Th17‐cell fractions remained stable after 72 h of post‐fixation storage. Delayed pre‐fixation reduced precision. Age and sex did not significantly influence Th17‐cell fractions, supporting a unified Th17‐cell reference interval of T‐helper cells [0.21%–1.7%]. Compared with healthy controls, Th17‐cell fractions were significantly lower in patients with STAT3 variants, patients with HIES or with both. ROC and MCC analyses indicated that Th17‐cell fractions above 0.44% reliably excluded pathogenic variants or associated phenotypes in all patient groups. This validated Th17‐cell assay is robust, reproducible and suitable for clinical use. It can guide genetic testing in IEI by identifying patients with Th17‐cell deficiencies and excluding variants or phenotypes unlikely to be causative.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT3 Transcription FactorTh17 CellsFlow CytometrySTAT1 Transcription FactorJob SyndromeCandidiasis, Chronic MucocutaneousHumansMaleFemaleAdultYoung AdultMiddle AgedAdolescent

Stichwörter der Autor:innen

STAT1 and STAT3Th17 lymphocytesdiagnostic techniquesflow cytometryimmunologyprimary immunodeficiency

Substanzen

STAT3 Transcription FactorSTAT1 Transcription FactorSTAT3 protein, humanSTAT1 protein, human

Autor:innen und Institutionen

  • Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark.

ORCID-Profile: Marie Juhl Toft, Mette Christiansen, Carsten Schade Larsen, Mette Holm, Nicklas Heine Staunstrup, Bjarne Kuno Møller, Mikkel Steen Petersen, Jens Magnus Bernth Jensen

Förderung

  • Innovation Fund Denmark
  • Innovationsfonden

Zitieren

APA

Toft, M. J., Sørensen, C. D., Christiansen, M., Larsen, C. S., Holm, M., Nedergaard, D., Hansen, R., Egedal, L. H., Staunstrup, N. H., Møller, B. K., Petersen, M. S., & Jensen, J. M. B. (2026). From Validation to Clinical Interpretation: A Flow Cytometric Th17‐Cell Assay for STAT1 ‐ and STAT3 ‐Related Inborn Errors of Immunity. Scandinavian Journal of Immunology, 104(2). https://doi.org/10.1111/sji.70140

Vancouver

Toft MJ, Sørensen CD, Christiansen M, Larsen CS, Holm M, Nedergaard D, et al. From Validation to Clinical Interpretation: A Flow Cytometric Th17‐Cell Assay for STAT1 ‐ and STAT3 ‐Related Inborn Errors of Immunity. Scandinavian Journal of Immunology. 2026;104(2). doi:10.1111/sji.70140

BibTeX
@article{Toft2026,
  author = {Toft, Marie Juhl and Sørensen, Camilla Darum and Christiansen, Mette and Larsen, Carsten Schade and Holm, Mette and Nedergaard, Dinna and Hansen, Rita and Egedal, Lone Højbjerg and Staunstrup, Nicklas Heine and Møller, Bjarne Kuno and Petersen, Mikkel Steen and Jensen, Jens Magnus Bernth},
  title = {From Validation to Clinical Interpretation: A Flow Cytometric Th17‐Cell Assay for STAT1 ‐ and STAT3 ‐Related Inborn Errors of Immunity},
  journal = {Scandinavian Journal of Immunology},
  year = {2026},
  volume = {104},
  number = {2},
  doi = {10.1111/sji.70140}
}
Kostenlos starten →